A Case Report on Mucormycosis in Non-Diabetic, Non-Covid Recovered Patient with no History of Steroid use
International Journal of Medical and Pharmaceutical Case Reports,
Rhino cerebral orbital mucormycosis is an aggressively spreading fungal infection caused by filamentous fungi of the Mucoraceae family and is found to be more prone in patients with comorbidities that include: uncontrolled diabetes mellitus, immune-suppressed patients, iron and aluminum overload, chronic steroid therapy, severe trauma, and protein-energy malnutrition.
A 51year old male patient was admitted to the hospital with a complaint of headache and intermittent fever. The patient had no history of diabetes or denovo hypertension. Based on the analysis of histopathological and radiological investigations, the patient was diagnosed with mucormycosis. The patient furthermore underwent an endoscopic surgical debridement followed by standard treatment including antifungal antibiotic(amphotericin-B) and azole antifungals (posaconazole) along with symptomatic treatment. Though the patient was given all possible therapy available, no improvement was seen in the patient's condition (poor prognosis).
How to Cite
Uğurlu ŞK, Selim S, Kopar A, Songu M. Rhino-orbital mucormycosis: clinical findings and treatment outcomes of four cases. Turkish Journal of Ophthalmology. 2015;45(4):169.
Afroze S, Korlepara R, Rao G, Madala J. Mucormycosis in a diabetic patient: A case report with an insight into its pathophysiology. Contemp Clin Dent. 2017;8(4):662.
Ahmad R, Noshi M, Khan T, Jr D, Richard L. Case report of rhino-orbital mucormycosis in a diabetic, with excellent outcome. Br J Med Med Res. 2015;7(4): 332–40.
Sen M, Lahane S, Lahane TP, Parekh R, Honavar SG. Mucor in a viral land: A tale of two pathogens. Indian J Ophthalmol. 2021;69(2):244–52.
Yohai RA, Bullock JD, Aziz AA, Markert RJ. Survival factors in rhino-orbital-cerebral mucormycosis. Surv Ophthalmol. 1994;39(1):3–22.
Bhansali A, Bhadada S, Sharma A, Suresh V, Gupta A, Singh P, et al. Presentation and outcome of rhino-orbital-cerebral mucormycosis in patients with diabetes. Postgrad Med J. 2004;80(949):670–4.
Mathebula SD. Rhino-orbital mucormycosis. Afr Vis Eye Health [Internet]. 2006;65(2).
Venkatesh D, Dandagi S, Chandrappa PR, Hema KN. Mucormycosis in immunocompetent patient resulting in extensive maxillary sequestration. Journal of oral and maxillofacial pathology: JOMFP. 2018 Jan;22(Suppl 1):S112.
Veisi A, Bagheri A, Eshaghi M, Rikhtehgar MH, Rezaei Kanavi M, Farjad R. Rhino-orbital mucormycosis during steroid therapy in COVID-19 patients: A case report. Eur J Ophthalmol. 2021;11206721211009450.
Tran D, Schmit B. An Aggressive Case of Mucormycosis. Cureus. 2020;12(8).
News Desk. Mucormycosis case reported in Formosa, Argentina [Internet]. Outbreaknewstoday.com. 2021 [cited 2021 Jul 14].
Gutiérrez-Delgado EM, Treviño-González JL, Montemayor-Alatorre A, Ceceñas-Falcón LA, Ruiz-Holguín E, Andrade-Vázquez CJ, et al. Chronic rhino-orbito-cerebral mucormycosis: A case report and review of the literature. Ann Med Surg (Lond). 2016;6:87–91.
Spellberg B, Ibrahim AS. Recent advances in the treatment of mucormycosis. Curr Infect Dis Rep. 2010;12(6):423–9.
Abstract View: 156 times
PDF Download: 54 times